Ethical Issues of Gene Therapy

Ethical Issues of Gene Therapy Photo
  The world trade market for cell and gene based therapies is expected to greater than the $20 billion USD mark by 2025, with an annual growth rate of 21%. The main targets for cell based therapies are high impact disease areas with significant incurable needs, including cancer, heart disease, neurodegenerative diseases, musculoskeletal disorders and autoimmune diseases.gene therapies should then not be rushed to market but companies should gather the required data about the impact of therapy in human community with the appropriate duration of follow-up to allow proper evaluation by payers. In addition, it is key to think about potential reimbursement of the techniques and also the pricing strategies, including risk sharing, as soon as the early clinical development phase.

Are you interested in

Mail us at

Program Enquiry
genetherapy@geneconferences.com
General Queries
genetherapy@alliedconferences.org
Sponsors/Exhibiting/Advertising
sponsoraac@alliedacademies.com
More details about sponsorship:sponsors@alliedacademies.com

Authorization Policy


Copyright © 2018-2019 Allied Academies, All Rights Reserved.